Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Completion of Placing

31st Oct 2007 07:01

Seeing Machines Limited31 October 2007 31 October 2007 Seeing Machines Limited ("Seeing Machines" or the "Company") Completion of Placing, Issue of Shares, Directors' Interests and Change in Shareholdings Seeing Machines (AIM: SEE), a leading developer of advanced computer basedimaging software systems, has completed the combined placings, the subject ofthe announcements made on 24 and 25 September and 26 October, issuing a further47,652,000 ordinary shares at 2.5p per share bringing the total number of newordinary shares issued in the placings to 56,000,000 ordinary shares. TheCompany has raised £1.4 million before expenses in the placings. The further47,652,000 new ordinary shares have been admitted for trading on AIM today. Thisbrings the total share capital of the company to 312,164,929. Following the issue of these 47,652,000 new ordinary shares the Company is awareof the following relevant changes in directors' and connected persons'shareholdings and substantial and significant shareholdings as defined in theAIM Rules for Companies. Directors and Connected Persons Shareholdings+------------+----+--------------------------+--------------------------+| |Note| To 30 October 2007| As of 31 October 2007|+------------+----+-----------+--------------+-----------+--------------+|Shareholder | |Shares Held|% shareholding|Shares Held|% shareholding|+------------+----+-----------+--------------+-----------+--------------+|Alexander | 1| 85,594,176| 32.36%| 85,644,264| 27.44%||Zelinsky1 | | | | | |+------------+----+-----------+--------------+-----------+--------------+|Trent | | | | 50,088| 0.02%||William | | | | | ||Victor | | | | | |+------------+----+-----------+--------------+-----------+--------------+|Rob Sale2 | 2| 5,115,512| 0.84%| 5,115,512| 0.71%|+------------+----+-----------+--------------+-----------+--------------+|Nick Cerneaz| | 391,914| 0.15%| 1,467,332| 0.47%|+------------+----+-----------+--------------+-----------+--------------+|William | 3| | | 400,704| 0.13%||Mobbs3 | | | | | |+------------+----+-----------+--------------+-----------+--------------+|David Gaul4 | 4| 1,000,000| 0.38%| 1,834,000| 0.59%|+------------+----+-----------+--------------+-----------+--------------+ 1. Alexander Zelinsky, a director of Seeing Machines, holds 25% of the issuedshares in JATS Technology Pty Ltd which has 85,594,176 ordinary shares in SeeingMachines. Mr. Zelinsky holds 50,088 Seeing Machines shares in his own name. 2. Rob Sale's shares are 2,209,143 shares held in the name of Caffe Pty Ltd ATFthe R C Sale Superannuation Fund and 2,906,369 shares held by rob's wife PaulaKay Sale. 3. William Mobbs shares are held in the names of William Mobbs and CatherineHolbery ATF The Bilbo Super Fund 4. David Gaul holds 1,834,000 shares through his company Jaiclimb Pty Limited. Significant and Substantial Shareholdings+-----------------+---------------------------+---------------------------+| | To 30 October 2007| As of 31 October 2007|+-----------------+------------+--------------+-----------+---------------+|Shareholder | Shares Held|% shareholding|Shares Held| % shareholding|+-----------------+------------+--------------+-----------+---------------+|JATS Technology | 85,594,176| 32.36%| 85,594,176| 27.42%||Pty Limited1 | | | | |+-----------------+------------+--------------+-----------+---------------+|Australian | 36,462,867| 13.78%| 36,462,867| 11.68%||National | | | | ||University | | | | |+-----------------+------------+--------------+-----------+---------------+|Volvo | 23,226,073| 8.78%| 23,226,073| 7.44%||Technological | | | | ||Development | | | | |+-----------------+------------+--------------+-----------+---------------+|Volvo Technology | | | 16,000,000| 5.13%||Transfer AB | | | | |+-----------------+------------+--------------+-----------+---------------+|Pershing Keen | 10,916,642| 4.13%| 10,916,642| 3.50%||Nominees Limited | | | | |+-----------------+------------+--------------+-----------+---------------+|HSBC Global | | | 10,000,000| 3.20%||Custody Nominee | | | | ||(UK) Limited | | | | |+-----------------+------------+--------------+-----------+---------------+|Pershing Keen | 9,264,999| 4%| 9,264,999| 2.97%||Nominees Limited | | | | |+-----------------+------------+--------------+-----------+---------------+|Roy Nominees | 9,165,000| 3.46%| 9,165,000| 2.94%||Limited | | | | |+-----------------+------------+--------------+-----------+---------------+ --- ENDS --- Enquiries: Seeing Machines Limited Insinger de Beaufort Parkgreen CommunicationsNick Cerneaz, CEO Peter Ward, Chris Justine Howarth, Erica Nelson Caldwell +61 (0) 2 6125 6501 +44 (0) 20 7190 7015 +44 (0) 20 7851 7480www.seeingmachines.com Notes to editors: About Seeing Machines Seeing Machines is an award winning Technology Company which focuses on visionbased human machine interfaces. Formed in 2000 in Canberra, Australia, SeeingMachines' purpose is to commercialise its computer-vision across a range ofindustries and applications. Seeing Machines deliver advanced computer vision solutions for researches anddevelopers in human factors, transportation safety, computer human interaction,robotics, medical research and psychology. The flagship product faceLAB(R)provides an automated and contact-free gaze and head tracking technology, itsolves the problem of observing human behaviour naturally, non-intrusively andwith a high degree of accuracy and usability. Building on these unique facetracking and pupil measurement and monitoring capabilities, the TrueFieldAnalyzer(R) is new medical device to assist clinicians detect and manage eyediseases such as glaucoma. The TrueField Analyzer(R) offers a new objective method to help doctors diagnoseand manage a range of eye diseases including glaucoma, age related maculardegeneration and diabetic retinopathy. Glaucoma affects about 2-3% of thepopulation over 40 years of age and is a leading source of blindness. Unlikemost other devices available to the clinician the TrueField Analyzer is acompletely objective test and it is quick and easy for patients and techniciansalike. The device measures both eyes concurrently and due to the reliabilitythat arises from the objective nature of the test, it has the potential tobecome a new standard in the measurement of visual field defects and thus in thediagnosis and management of disease such as glaucoma. More generally Seeing Machines' computer vision systems are able to measure theorientation and position of a human head, estimate eye-gaze direction, detecteye blinks and track other facial features. This functionality is achievedentirely though visual means, using video cameras connected to advanced imageprocessing software, with no attachments required on the subject. Products suchas faceLAB(R) are designed to allow human factors researchers and designers toassess the interaction of an operator in an environment and this findsapplication in designing operator environments, such as cockpits for cars,trucks, trains, and aeroplanes for instance, and other industrial designapplications, as well as medical and psychological research situations. Thetechnology has been developed into the Driver State Sensor (DSS2) product forapplication in monitoring vehicle drivers and if it detects drowsiness (fatigue)or that the driver is distracted and their attention has been diverted from theroad, alarms are raised to alert the driver to these events. In largerdeployments, such as in fleet and mining equipment operations, the data isavailable in both real-time and off-line modes for fleet management, drivertraining and awareness programs The systems work in real-time, enabling the behaviour of subjects to be trackedin real-time. This technology is paving the way in promoting safer drivingconditions and works to enhance the driving experience and to eliminateaccidents caused through driver drowsiness or distraction. There are many different sectors that can benefit from this revolutionarysoftware, for which it has been developed, including: automotive; academicresearch; medicine/healthcare; defence; autostereoscopy (next generationdisplays); sport; and games. This information is provided by RNS The company news service from the London Stock Exchange

Related Shares:

Seeing Machines
FTSE 100 Latest
Value8,275.66
Change0.00